Outset Medical, Inc.

Equities

OM

US6901451079

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-22 pm EDT			5-day change	1st Jan Change
3.905 ^USD	+6.11%		+9.69%	-27.82%

May. 14	Transcript : Outset Medical, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM
May. 13	Morgan Stanley Lowers Price Target on Outset Medical to $4.50 From $5.50, Keeps Equalweight Rating	MT

Outset Medical, Inc. Reaffirms Earnings Guidance for the Year 2024

May 08, 2024 at 04:02 pm EDT

Outset Medical, Inc. reaffirmed earnings guidance for the year 2024. The company reaffirmed its previously provided guidance for 2024 including revenue of $145 million to $153 million, growing 12% to 18% over 2023.

Latest news about Outset Medical, Inc.

Transcript : Outset Medical, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM	May. 14
Morgan Stanley Lowers Price Target on Outset Medical to $4.50 From $5.50, Keeps Equalweight Rating	May. 13	MT
Transcript : Outset Medical, Inc., Q1 2024 Earnings Call, May 08, 2024	May. 08
Earnings Flash (OM) OUTSET MEDICAL Reports Q1 Revenue $28.2M, vs. Street Est of $30.3M	May. 08	MT
Outset Medical, Inc. Reaffirms Earnings Guidance for the Year 2024	May. 08	CI
Outset Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Sector Update: Health Care Stocks Advance in Monday Afternoon Trading	May. 06	MT
Outset Medical Shares Rise on US FDA 510(k) Clearance for TabloCart With Prefiltration	May. 06	MT
Outset Medical Shares Rise 56% After FDA Grants Clearance for TabloCart	May. 06	DJ
Outset Medical Receives US FDA 510(k) Clearance for TabloCart With Prefiltration -- Shares Surge 13% Pre-Bell	May. 06	MT
Outset Medical, Inc. Receives FDA 510(K) Clearance for Tablocart with Prefiltration	May. 06	CI
Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S	Apr. 17	CI
BTIG Initiates Outset Medical at Buy Rating With $6 Price Target	Apr. 08	MT
Outset Medical, Inc. Announces Board Changes	Mar. 13	CI
RBC Reduces Price Target on Outset Medical to $5 From $6, Keeps Sector Perform Rating	Feb. 22	MT
Transcript : Outset Medical, Inc., Q4 2023 Earnings Call, Feb 21, 2024	Feb. 21
Earnings Flash (OM) OUTSET MEDICAL Reports Q4 Revenue $30.5M, vs. Street Est of $30.1M	Feb. 21	MT
Outset Medical, Inc. Announces Departure of Steve Williamson as Chief Commercial Officer, Effective March 1, 2024	Feb. 21	CI
Outset Medical, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 21	CI
Outset Medical, Inc. Reaffirms Earnings Guidance for 2024	Feb. 21	CI
North American Morning Briefing : Stock Futures -2-	Jan. 16	DJ
Outset Medical Shares Drop After RBC Downgrade	Jan. 12	MT
RBC Downgrades Outset Medical to Sector Perform From Outperform, Slashes Price Target to $6 From $14	Jan. 12	MT
Transcript : Outset Medical, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 05:15 PM	Jan. 08
Outset Medical, Inc. Provides Revenue Guidance for the Year 2024	Jan. 08	CI

Chart Outset Medical, Inc.

Duration

Period

More charts

Company Profile

Outset Medical, Inc. is a medical technology company. The Company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The Company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. Tablo Console is a compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-29 - Annual General Meeting

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Outset Medical, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

3.905 USD

Average target price

5.643 USD

Spread / Average Target

+44.50%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
OUTSET MEDICAL, INC.	-27.82%	202M
THERMO FISHER SCIENTIFIC	+11.31%	226B
DANAHER CORPORATION	+15.50%	198B
INTUITIVE SURGICAL, INC.	+18.83%	142B
BOSTON SCIENTIFIC CORPORATION	+30.38%	111B
SIEMENS HEALTHINEERS AG	+2.62%	65.26B
EDWARDS LIFESCIENCES CORPORATION	+18.31%	54.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.96%	50.94B
AGILENT TECHNOLOGIES, INC.	+9.95%	44.8B
GE HEALTHCARE TECHNOLOGIES INC.	+4.27%	36.8B

Other Advanced Medical Equipment & Technology